Neuroprotection

From Food & Medicine Encyclopedia

(Redirected from Neuroprotective agent)

Neuroprotection[edit]

File:Neuronehisto.jpg
Histological image of neurons

Neuroprotection refers to the mechanisms and strategies used to protect the nervous system from injury and degeneration. The primary goal of neuroprotection is to prevent or slow the progression of neurodegenerative diseases and to limit the extent of damage following neurological injury.

Mechanisms of Neuroprotection[edit]

Neuroprotection involves a variety of mechanisms that can be broadly categorized into the following:

Antioxidant Defense[edit]

Oxidative stress is a major contributor to neuronal damage. Antioxidants help to neutralize free radicals and reduce oxidative stress, thereby protecting neurons. Common antioxidants include vitamin E, vitamin C, and glutathione.

Anti-inflammatory Agents[edit]

Inflammation is a response to injury that can exacerbate neuronal damage. Anti-inflammatory agents, such as non-steroidal anti-inflammatory drugs (NSAIDs) and corticosteroids, can help reduce inflammation and protect neurons.

Excitotoxicity Inhibition[edit]

Excitotoxicity occurs when neurons are damaged and killed by excessive stimulation by neurotransmitters such as glutamate. Neuroprotective strategies aim to inhibit excitotoxicity by blocking glutamate receptors or reducing glutamate release.

Neurotrophic Factors[edit]

Neurotrophic factors are proteins that support the growth, survival, and differentiation of neurons. Examples include nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF). These factors can be used to promote neuronal survival and repair.

Applications of Neuroprotection[edit]

Neuroprotection is a critical area of research in the treatment of various neurological conditions, including:

Stroke[edit]

In the case of ischemic stroke, neuroprotective strategies aim to reduce the extent of brain damage by preserving neuronal function and preventing cell death.

Alzheimer's Disease[edit]

Neuroprotective approaches in Alzheimer's disease focus on reducing amyloid-beta accumulation, tau phosphorylation, and oxidative stress to slow disease progression.

Parkinson's Disease[edit]

In Parkinson's disease, neuroprotection aims to preserve dopaminergic neurons in the substantia nigra and reduce oxidative stress and inflammation.

Challenges and Future Directions[edit]

Despite significant research, effective neuroprotective therapies remain limited. Challenges include the complexity of the nervous system, the difficulty in delivering drugs across the blood-brain barrier, and the need for early intervention. Future research is focused on developing more targeted therapies and improving drug delivery methods.

Related pages[edit]

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.